TerrAscend (TER) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
13 Nov, 2025Opening remarks and agenda
Meeting held virtually to maximize shareholder participation, replicating the in-person experience.
Shareholders encouraged to submit questions on formal business items through the online platform.
Three main agenda items: election of directors, ratification of auditor, and approval of stock option amendments.
Board and executive committee updates
Five directors nominated: Craig Collard, Kara DioGuardi, Ira Duarte, Ed Schutter, and Jason Wild, to serve until the next annual meeting.
No additional nominations received; nominations closed as per bylaws.
Overview of voting outcomes
All agenda items passed with the required shareholder approval.
Directors elected, auditor ratified, and stock option amendment approved.
Voting conducted online, with results tabulated and confirmed by the scrutineer.
Latest events from TerrAscend
- Q4 and FY 2025 saw strong margins, positive cash flow, and disciplined expansion.TER
Q4 202512 Mar 2026 - All business items, including director elections and stock option extension, were approved.TER
AGM 20243 Feb 2026 - Revenue and EBITDA grew in Q2, with strong cash flow and $140M financing for expansion.TER
Q2 20241 Feb 2026 - Q3 revenue was $74.2M, with strong margins, Ohio entry, and a $140M loan supporting growth.TER
Q3 202416 Jan 2026 - FY 2024 revenue hit $306.7M with strong cash flow, margin gains, and Ohio expansion.TER
Q4 20241 Dec 2025 - Q1 2025 saw margin gains, positive cash flow, and expansion into Ohio and New Jersey.TER
Q1 202526 Nov 2025 - Gross margin rose to 51.1% as focus shifted to Northeast markets and debt reduction.TER
Q2 202523 Nov 2025 - Q3 revenue steady at $65.1M, margins up, and strong cash flow supports future growth.TER
Q3 202518 Nov 2025 - Expanding market share and disciplined execution drive margin and cash flow improvements.TER
Investor Presentation22 Jul 2025